Columbia Lab-to-Market Accelerator Network

Columbia has extensive experience founding and supporting successful accelerator programs to provide our promising early‐stage technologies with mentorship and support resources, direct funding, educational boot camps, networking opportunities with industry representatives and the venture investor community.

The Columbia Lab-to-Market (L2M) Accelerator Network serves as a framework to successfully develop, launch, and execute initiatives that help commercialize academic research. Since 2008, Columbia University has launched and co-founded a diverse portfolio of accelerator programs spanning therapeutics, diagnostics, medical devices, clean energy, advanced materials, artificial intelligence, pathogen surveillance, blockchain, carbontech, and smart cities. These programs provide funding and resources to advance early-stage, deep-tech teams from early concept to commercialization.  

Collectively, the Columbia L2M accelerators have led to very impressive results that have grown exponentially with over 2000 applications received, 814 teams run through educational bootcamps on product development and entrepreneurship, 416 cash awards of $60.5M awarded, 100+ startups launches, and over $288M in external follow-on funding raised by those teams.

To learn more about the individual member programs that comprise the Columbia Lab-to-Market Accelerator Network, please visit: https://labtomarket.columbia.edu/ or contact [email protected].